Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives

Chimeric antigen receptor (CAR) T-cell therapy has significantly advanced the treatment of patients with relapsed and refractory hematologic malignancies and is increasingly investigated as therapeutic option of other malignancies. The main adverse effect of CAR T-cell therapy is potentially life-th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Coll Cardiol
Main Authors: Ganatra, Sarju, Carver, Joseph R., Hayek, Salim S., Ky, Bonnie, Leja, Monika J., Lenihan, Daniel J., Lenneman, Carrie, Mousavi, Negaresh, Park, Jae H., Perales, Miguel Angel, Ryan, Thomas D., Scherrer-Crosbie, Marriele, Steingart, Richard M., Yang, Eric H., Zaha, Vlad, Barac, Ana, Liu, Jennifer E.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211027/
https://ncbi.nlm.nih.gov/pubmed/31856973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.10.049
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker